These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23533167)

  • 1. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
    Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
    J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
    Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
    Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
    Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
    Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma.
    Liu Y; Hei Y; Shu Q; Dong J; Gao Y; Fu H; Zheng X; Yang G
    PLoS One; 2012; 7(4):e35800. PubMed ID: 22536440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
    Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
    Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
    Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
    Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
    Ming F; Sun Q
    Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.
    Ramaswamy B; Majumder S; Roy S; Ghoshal K; Kutay H; Datta J; Younes M; Shapiro CL; Motiwala T; Jacob ST
    Mol Endocrinol; 2009 Feb; 23(2):176-87. PubMed ID: 19095770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.
    Huang YT; Li FF; Ke C; Li Z; Li ZT; Zou XF; Zheng XX; Chen YP; Zhang H
    J Transl Med; 2013 Oct; 11():245. PubMed ID: 24090193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.
    Yamamoto S; Tomita Y; Nakamori S; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M; Aozasa K
    J Clin Oncol; 2003 Feb; 21(3):447-52. PubMed ID: 12560433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cell cycle regulator VCP (p97/CDC48) as a substrate of the band 4.1-related protein-tyrosine phosphatase PTPH1.
    Zhang SH; Liu J; Kobayashi R; Tonks NK
    J Biol Chem; 1999 Jun; 274(25):17806-12. PubMed ID: 10364224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients.
    Li SY; Li R; Chen YL; Xiong LK; Wang HL; Rong L; Luo RC
    BMC Genet; 2014 Jun; 15():67. PubMed ID: 24919593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma.
    Yan Q; Zhang ZF; Chen XP; Gutmann DH; Xiong M; Xiao ZY; Huang ZY
    Int J Oncol; 2008 May; 32(5):1057-63. PubMed ID: 18425332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Suppression Mechanisms of Protein Tyrosine Phosphatase O and Clinical Applications.
    Kang MM; Shan SL; Wen XY; Shan HS; Wang ZJ
    Asian Pac J Cancer Prev; 2015; 16(15):6215-23. PubMed ID: 26434819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.